**Core Concept**
Malignant hyperthermia (MH) is a rare but life-threatening medical emergency that occurs in response to certain anesthetic agents, leading to an uncontrolled rise in body temperature, metabolic rate, and muscle rigidity. It is a pharmacogenetic disorder triggered by specific anesthetics.

**Why the Correct Answer is Right**
Malignant hyperthermia is caused by the administration of volatile anesthetics, such as halothane, isoflurane, or sevoflurane, and depolarizing muscle relaxants, like succinylcholine. These agents trigger an abnormal response in the skeletal muscle cells, leading to an excessive release of calcium ions. This results in muscle rigidity, hypermetabolism, and an increase in body temperature. The combination of succinylcholine and halothane is particularly hazardous, as it can trigger a severe MH reaction in susceptible individuals.

**Why Each Wrong Option is Incorrect**
**Option B:** Propranolol is a beta-blocker used to manage hypertension, tachycardia, and other cardiovascular conditions. It is not associated with malignant hyperthermia.
**Option C:** Lidocaine is a local anesthetic and antiarrhythmic medication that can cause systemic toxicity at high doses, but it is not a trigger for malignant hyperthermia.
**Option D:** Bupivacaine is a long-acting local anesthetic that can cause cardiovascular toxicity and systemic complications, but it is not linked to malignant hyperthermia.

**Clinical Pearl / High-Yield Fact**
When managing a patient in the perioperative period, it's essential to identify and avoid triggering agents for malignant hyperthermia, such as succinylcholine and volatile anesthetics. A careful review of the patient's medical history, family history, and genetic predisposition can help prevent this potentially fatal condition.

**✓ Correct Answer: A. Succinylcholine + halothane**